Fig. 10From: Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical studyPhosphorylation levels of ACBD3 protein in various tumors. A Summary of the correlation between various cancers and ACBD3 phosphorylation sites; B breast invasive carcinoma (BRCA); C head and neck squamous cell carcinoma (HNSC); D lung adenocarcinoma (LUAD); E kidney renal clear cell carcinoma (KIRC); F glioblastoma multiforme (GBM). The S316 locus expressed an upper phosphorylation level in BRCA when compared with normal tissues. The S20 locus exhibited a lower phosphorylation level in HNSC, and LUAD is the opposite. The S43 locus expressed an upper phosphorylation level in KIRC, LUAD, and GBM, and decreased in HNSCBack to article page